
Congratulations to Myricx Bio, a spinout co-founded by @TateScience based on research from @impchemistry & @TheCrick, which has raised £90m to move its novel cancer treatment into clinical development 👏 @RoySocChem #startup #cancer @imperialcollege imperial.ac.uk/news/254635/i…











